Traws Pharma Free Cash Flow (FCF) History (TRAW)

Traws Pharma reported −$20.8M in free cash flow for fiscal 2025, an increase of $12.7M from the previous fiscal year, with a free cash flow margin of −744.44%.

View full Traws Pharma company overview

Traws Pharma free cash flow by year

Traws Pharma annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−$20.8M$12.7M−744.44%
20242024-12-31−$33.4M−$15.5M−14796.46%
20232023-12-31−$17.9M$5.1M−7940.71%
20202020-12-31−$23.1M$34.8M−9995.67%
20142014-12-31−$57.9M$4.1M−7234.50%
20132013-12-31−$62.0M−$63.3M−1304.29%
20122012-12-31$1.4M$15.8M+2.93%
20112011-12-31−$14.4M−970.21%

Traws Pharma free cash flow growth trends

Over the last five reported fiscal years, free cash flow grew from −$62.0M to −$20.8M, a net increase of $41.2M. Traws Pharma's latest reported quarter, Q3 2024, generated −$11.5M in free cash flow, an increase of $2.7M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Traws Pharma filings at SEC.gov ↗